We are monitoring the impact of COVID-19 on APAC BioSurgery Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2660
Share on
Share on

Asia Pacific BioSurgery Market Research Report - Segmented By Type, By Application, & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 2660
Pages: 143

APAC BioSurgery Market Size (2020 to 2025)

The size of the BioSurgery Market in the Asia Pacific was worth USD 3.89 billion in 2020 and is estimated to be growing at a CAGR of 10.43% to reach USD 6.39 billion by 2025 during the forecast period.

Biomaterials are biologically compatible glues used to seal surgical incisions, or lubricants to help joint movement or support structures on which living tissue is grown or shaped. Still, the term also covers biocompatible materials such as hip replacements and artificial pacemakers. It also includes bio-therapeutic techniques such as gene and cellular therapies. All these techniques combined make up the field of bio-surgery.

Biosurgery products help enhance the work efficiency of physicians by controlling surgery-related difficulties inexpensive and complicated surgeries. It utilizes biomaterial, therapeutic, and sophisticated device technologies to improve patients' health in the orthopedic and post-surgery care departments.

The primary factor affecting the Bio Surgery market is the increasing number of surgeries carried out due to changing lifestyles. Additionally, the popularity of sports has led to an increase in the number of spine-related injuries. The rise in the geriatric population is the primary driver of the market in the region.

However, the industry is still plagued by the increasing costs of surgeries, the growing demand for minimally invasive techniques, and the stringent government regulations and reimbursement policies, all of which restrain the market growth.

This research report on the Asia Pacific BioSurgery Market has been segmented and sub-segmented into the following categories.

  • By Type: Sealants, Haemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Substitutes, and Staple line Reinforcement Agents
  • By Application: Orthopaedic, General, Neurological, Cardiovascular, Reconstructive, Gynaecological, Urological, and thoracic Surgeries.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Geographically, The APAC biosurgery market is projected to witness a high CAGE during the analysis period due to the growing prevalence of chronic diseases. Additionally, rising per capita income tends to upgrade the living standards, the ever-increasing amount spent on healthcare, and increasing awareness among the people associated with the biosurgery market in this region.

The Chinese biosurgery market is estimated to lead the market in this region during the analysis period due to rising chronic disorders, increasing chronic diseases such as cardiac disorders and renal disorders. Also, valuable and beneficial measures taken for blood loss during surgeries are likely to augment these methods' obtainment over the forecasting framework.

The biosurgery market in India is anticipated to grow at the fastest rate in this region during the forecast period due to the rapid urbanization, massive population base, and rise in middle-class population with significant discretionary expenses and awareness about the advanced surgical processes are predicted to accelerate the growth of this country in this region.

Companies like Baxter International, C.R. Bard, Johnson & Johnson, Covidien PLC, Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group are playing a leading role in the Asia Pacific BioSurgery Market.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

  1. Market Segmentation

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Sealants   

                                                5.1.2.1 Natural

                                                5.1.2.2 Synthetic and Semi-Synthetic

                                5.1.3 Haemostatic Agents            

                                5.1.4 Adhesion Barriers

                                                5.1.4.1 Synthetic

                                                5.1.4.2 Natural

                                5.1.5 Soft Tissue Attachments   

                                                5.1.5.1 Synthetic Meshes

                                                5.1.5.2 Biological Meshes

                                5.1.7 Bone Graft Substitutes      

                                                5.1.7.1 Bone Allografts

                                                5.1.7.2 Demineralized Bone Matrix

                                                5.1.7.3 Bone Morphogenetic Proteins

                                                5.1.7.4 Synthetic Bone Grafts

                                5.1.8 Staple Line Reinforcement Agents

                                5.1.9 Y-o-Y Growth Analysis, By Type     

                                5.1.10 Market Attractiveness Analysis, By Type

                                5.1.11 Market Share Analysis, By Type   

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Orthopaedic           

                                5.2.3 General    

                                5.2.4 Neurological           

                                5.2.5 Cardiovascular       

                                5.2.6 Reconstructive      

                                5.2.7 Gynaecological      

                                5.2.8 Urological

                                5.2.9 Thoracic    

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

  1. Geographical Analysis

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

  1. Strategic Analysis

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

  1. Market Leaders' Analysis

                8.1 Baxter International               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 C.R. Bard                      

                8.3 Covidien PLC                              

                8.4 Johnson & Johnson                 

                8.5 Sanofi Group                             

                8.6 Atrium Medical Corporation                

                8.7 B.Braun Melsungen AG                         

                8.8 Cryolife Inc.                

                8.9 Stryker Corporation                

                8.10 Haemostasis LLC                    

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific BioSurgery Market, By Type, From 2020 to 2025 (USD Billion)
  2. Asia Pacific Sealants Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia Pacific Haemostatic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia Pacific Adhesion Barriers Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia Pacific Soft Tissue Attachments Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia Pacific Bone Graft Substitutes Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia Pacific Staple Line Reinforcement Agents Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia Pacific BioSurgery Market, By Application, From 2020 to 2025 (USD Billion)
  9. Asia Pacific Orthopaedic Market, By Region, From 2020 to 2025 (USD Billion)
  10. Asia Pacific General Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia Pacific Neurological Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia Pacific Cardiovascular Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia Pacific Reconstructive Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia Pacific Gynaecological Market, By Region, From 2020 to 2025 (USD Billion)
  15. Asia Pacific Urological Market, By Region, From 2020 to 2025 (USD Billion)
  16. Asia Pacific Thoracic Market, By Region, From 2020 to 2025 (USD Billion)
  17. Japan Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  18. Japan Bio Surgery Market, By Application, From 2020 to 2025 (USD Billion)
  19. China Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  20. China Bio Surgery Market, By Application, From 2020 to 2025 (USD Billion)
  21. India Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  22. India Bio Surgery Market, By Application, From 2020 to 2025 (USD Billion)
  23. Australia Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  24. Australia Bio Surgery Market, By Application, From 2020 to 2025 (USD Billion)
  25. South Korea Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  26. South Korea Bio Surgery Market, By Application, From 2020 to 2025 (USD Billion)
  27. Asia Pacific Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  28. Asia Pacific Natural Market, By Region, From 2020 to 2025 (USD Billion)
  29. Asia Pacific Synthetic Market, By Region, From 2020 to 2025 (USD Billion)
  30. Asia Pacific Synthetic Meshes Market, By Region, From 2020 to 2025 (USD Billion)
  31. Asia Pacific Biological Meshes Market, By Region, From 2020 to 2025 (USD Billion)
  32. Asia Pacific Bone Allografts Market, By Region, From 2020 to 2025 (USD Billion)
  33. Asia Pacific Demineralized Bone Matrix Market, By Region, From 2020 to 2025 (USD Billion)
  34. Asia Pacific Bone Morphogenic Proteins Market, By Region, From 2020 to 2025 (USD Billion)
  35. Asia Pacific Synthetic Bone Grafts Market, By Region, From 2020 to 2025 (USD Billion)
  36. Japan Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  37. China Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  38. India Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)
  39. Australia Bio Surgery Market, By Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample